These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 19250642

  • 1. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
    Ma P, Luo Y, Zhu X, Ma H, Hu J, Tang S.
    Biochem Biophys Res Commun; 2009 Mar 06; 380(2):402-6. PubMed ID: 19250642
    [Abstract] [Full Text] [Related]

  • 2. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K, Jesmin S, Maeda S, Zaedi S, Shimojo N, Miyauchi T, Goto K.
    Exp Biol Med (Maywood); 2006 Jun 06; 231(6):1090-4. PubMed ID: 16741055
    [Abstract] [Full Text] [Related]

  • 3. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K, Yanagi Y, Tamaki Y, Usui T, Kubota N, Iriyama A, Terauchi Y, Kadowaki T, Araie M.
    Invest Ophthalmol Vis Sci; 2006 Oct 06; 47(10):4547-52. PubMed ID: 17003451
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP.
    Invest Ophthalmol Vis Sci; 2007 Feb 06; 48(2):858-65. PubMed ID: 17251488
    [Abstract] [Full Text] [Related]

  • 5. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K, Goto K, Jesmin S, Maeda S, Miyauchi T, Kaji Y, Oshika T, Hori S.
    Curr Eye Res; 2006 Jan 06; 31(1):79-89. PubMed ID: 16421022
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
    Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, Musashi K, Yoshimura N.
    Invest Ophthalmol Vis Sci; 2005 Apr 06; 46(4):1440-4. PubMed ID: 15790913
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of a coumarin derivative in diabetic rats.
    Bucolo C, Ward KW, Mazzon E, Cuzzocrea S, Drago F.
    Invest Ophthalmol Vis Sci; 2009 Aug 06; 50(8):3846-52. PubMed ID: 19279317
    [Abstract] [Full Text] [Related]

  • 8. Role of angiotensin II in retinal leukostasis in the diabetic rat.
    Chen P, Scicli GM, Guo M, Fenstermacher JD, Dahl D, Edwards PA, Scicli AG.
    Exp Eye Res; 2006 Nov 06; 83(5):1041-51. PubMed ID: 16822509
    [Abstract] [Full Text] [Related]

  • 9. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.
    Yamagishi S, Matsui T, Nakamura K, Takeuchi M, Imaizumi T.
    Microvasc Res; 2006 Nov 06; 72(1-2):86-90. PubMed ID: 16797605
    [Abstract] [Full Text] [Related]

  • 10. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E, Poulaki V, Mitsiades N, Mitsiades CS, Miller JW, Gragoudas ES.
    Invest Ophthalmol Vis Sci; 2009 Oct 06; 50(10):4898-904. PubMed ID: 19553613
    [Abstract] [Full Text] [Related]

  • 11. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
    Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW.
    Invest Ophthalmol Vis Sci; 2007 Nov 06; 48(11):5152-9. PubMed ID: 17962468
    [Abstract] [Full Text] [Related]

  • 12. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.
    Barouch FC, Miyamoto K, Allport JR, Fujita K, Bursell SE, Aiello LP, Luscinskas FW, Adamis AP.
    Invest Ophthalmol Vis Sci; 2000 Apr 06; 41(5):1153-8. PubMed ID: 10752954
    [Abstract] [Full Text] [Related]

  • 13. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrósio AF, Forrester JV.
    Invest Ophthalmol Vis Sci; 2007 Nov 06; 48(11):5257-65. PubMed ID: 17962481
    [Abstract] [Full Text] [Related]

  • 14. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Sep 06; 48(9):4342-50. PubMed ID: 17724226
    [Abstract] [Full Text] [Related]

  • 15. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
    Hattori T, Matsubara A, Taniguchi K, Ogura Y.
    Curr Eye Res; 2010 Feb 06; 35(2):146-54. PubMed ID: 20136425
    [Abstract] [Full Text] [Related]

  • 16. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B, Sun JH, Xiang FF, Liu L, Li WJ.
    Exp Eye Res; 2012 May 06; 98():37-43. PubMed ID: 22449442
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
    Kowluru RA, Menon B, Gierhart DL.
    Invest Ophthalmol Vis Sci; 2008 Apr 06; 49(4):1645-51. PubMed ID: 18385086
    [Abstract] [Full Text] [Related]

  • 18. Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats.
    Zhu B, Wang W, Gu Q, Xu X.
    Exp Eye Res; 2008 Feb 06; 86(2):375-82. PubMed ID: 18191124
    [Abstract] [Full Text] [Related]

  • 19. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
    Zheng Z, Chen H, Xu X, Li C, Gu Q.
    Exp Eye Res; 2007 Apr 06; 84(4):745-52. PubMed ID: 17303121
    [Abstract] [Full Text] [Related]

  • 20. VEGF164 is proinflammatory in the diabetic retina.
    Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, Amano S, Hida T, Oguchi Y, Adamis AP.
    Invest Ophthalmol Vis Sci; 2003 May 06; 44(5):2155-62. PubMed ID: 12714656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.